Coexisting Neurotransmitters in Central Noradrenergic Neurons

P. V. Holmes and J. N. Crawley
Section on Behavioral Neuropharmacology
Experimental Therapeutics Branch
National Institute of Mental Health
Bethesda, Maryland 20892



1. Akaoka H, Aston-Jones G. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J Neurosci 1991;11:3830–3839.

2. Angulo JA, Printz D, Ledoux M, McEwen BS. Isolation stress increases tyrosine hydroxylase mRNA in the locus coeruleus and midbrain and decreases proenkephalin mRNA in the striatum and nucleus accumbens. Mol Brain Res 1991;11:301–308.

3. Austin MC, Cottingham SL, Paul SM, Crawley JN. Tyrosine hydroxylase and galanin mRNA levels in locus coeruleus neurons are increased following reserpine administration. Synapse 1990;6:351–357.

4. Bartfai T, Fisone G, Langel Ü. Galanin and galanin antagonists: molecular and biochemical perspectives. Trends Pharmacol Sci 1992;6:351–357.

5. Beal MF, Clevens RA, Chattha GK, MacGarvey UM, Mazurek MF, Gabriel SM. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia in cerebral cortex. J Neurochem 1988;51:1935–1941.

6. Beal MF, MacGarvey U, Swartz KJ. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease. Ann Neurol 1990;28:157–161.

7. Berrettini WH, Kaye WH, Sunderland T, May C, Gwirtsman HE, Mellow A, Albright A. Galanin immunoreactivity in human CSF: studies in eating disorders and Alzheimer's disease. Neuropsychobiology 1988;19:64–68.

8. Blasco I, Alvarez FJ, Villalba RM, Solana ML, Martinez-Murillo R, Rodrigo J. Light and electron microscopic study of galanin-immunoreactive nerve fibers in the rat posterior thalamus. J Comp Neurol 1989;283:1–12.

9. Bloch GJ, Butler PC, Kohler JG, Bloch DA. Microinjection of galanin into the medial preoptic nucleus facilitiates copulatory behavior in the male rat. Physiol Behav 1993;54:615–624.

10. Chadi G, Tinner B, Agnati LF, Fuxe K. Basic fibroblast growth factor (bFGF, FGF-2) immunoreactivity exists in the noradrenaline, adrenaline and 5-HT nerve cells of the rat brain. Neurosci Lett 1993;160:171–176.

11. Chan-Palay V. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J Comp Neurol 1988;273:543–557.

12. Chen Y, Laburthe M, Amiranoff B. Galanin inhibits adenylate cyclase of rat brain membranes. Peptides 1992;13:339–341.

13. Cole BJ, Robbins TW, Everitt BJ. Lesions of the dorsal noradrenergic bundle simultaneously enhance and reduce responsivity to novelty in a food preference test. Brain Res Rev 1988;13:325–349.

14. Cooper JR, Bloom FE, Roth RH. The biochemical basis of neuropharmacology, 6th ed. New York: Oxford University Press, 1991.

15. Cortes R, Ceccatell S, Schalling M, Hökfelt T. Differential effects of intracerebroventricular colchicine administration on the expression of mRNAs for neuropeptides and neurotransmitter enzymes, with special emphasis on galanin: an in situ hybridization study. Synapse 1990;6:369–391.

16. Corwin RL, Robinson JK, Crawley JN. Galanin antagonists block galanin-induced feeding in the hypothalamus and amygdala of the rat. Eur J Neurosci 1993;5:1528–1533.

17. Crawley JN, Austin MC, Fiske SM, Martin B, Consolo S, Berthold M, Langel U, Fisone G, Bartfai T. Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus. J Neurosci 1990; 10:3695–3700.

18. Crawley JN, Wenk GL. Coexistence of galanin and acetylcholine: is galanin involved in memory processes and dementia? Trends Neurosci 1989;12:278–282.

19. Everitt BJ, Hökfelt T. The coexistence of neuropeptide-Y with other peptides and amines in the central nervous system. In: Mutt V, Fuxe K, Hökfelt T, Lundberg JM, eds. Neuropeptide Y. New York: Raven Press, 1989;61–71.

20. Finta EP, Regenold JT, Illes P. Depression by neuropeptide Y of noradrenergic inhibitory postsynaptic potentials of locus coeruleus neurons. Naunyn Schmiedebergs Arch Pharmacol 1992;346:472–474.

21. Flood JF, Hernandez EN, Morley JE. Modulation of memory processing by neuropeptide Y. Brain Res 1987;421:280–290.

22. Goldstein M, Deutch AY. The inhibitory actions of NPY and galanin on 3H-norepinephrine release in the central nervous system: Relation to a proposed hierarchy of neuronal coexistence. In: Mutt V, Fuxe K, Hökfelt T, Lundberg JM, eds. Neuropeptide Y. Karolinska Institute Nobel Conference Series. New York: Raven Press, 1989;153–162.

23. Heilig M, McLeod S, Brot M, Heinrichs S, Menzaghi F, Koob GF, Britton KT. Anxiolytic-like action of neuropeptide Y (NPY), but not other peptides in an operant conflict test. Neuropsychopharmacology 1993;8:357–363.

24. Herbert H, Saper CB. Cholecystokinin-, galanin-, and corticotropin-releasing factor-like immunoreactive projections from the nucleus of the solitary tract to the parabrachial nucleus in the rat. J Comp Neurol 1990;293:581–598.

25. Hökfelt T, Millhorn D, Seroogy K, Tsuruo Y, Ceccatelli S, Lindh B, Meister B, Melander T, Schalling M, Bartfai T, Terenius L. Coexistence of peptides with classical neurotransmitters. Experientia 1987;43:768–780.

26. Holets VR, Hökfelt T, Rökaeus Å, Terenius L, Goldstein M. Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus. Neuroscience 1988; 24:893–906.

27. Kaplan LM, Spindel ER, Isselbacher KJ, Chin WW. Tissue-specific expression of the rat galanin gene. Proc Natl Acad Sci USA 1988;85:1065–1069.

28. Kowall NW, Beal MF. Galanin-like immunoreactivity is present in human substantia innominata and in senile plaques in Alzheimer's disease. Neurosci Lett 1989;98:118–123.

29. Kyrkouli SE, Stanley BG, Hutchinson R, Seirafi RD, Leibowitz SF. Peptide–amine interactions in the hypothalamic paraventricular nucleus: analysis of galanin and neuropeptide Y in relation to feeding. Brain Res 1990;521:185–191.

30. Kyrkouli SE, Stanley BG, Leibowitz SF. Differential effects of galanin and neuropeptide Y on extracellular norepinephrine levels in the paraventricular hypothalamic nucleus of the rat: a microdialysis study. Life Sci 1992;51:203–210.

31. Lagny-Pourmir I, Epelbaum J. Regional stimulatory and inhibitory effects of guanine nucleotides on [125I]galanin binding in rat brain: relationship with the rate of occupancy of galanin receptors by endogenous galanin. Neuroscience 1992;49:829–847.

32. Larhammar D, Ericsson A, Persson H. Structure and expression of the rat neuropeptide Y gene. Proc Natl Acad Sci USA 1987;84:2068–2072.

33. Lechner J, Leah JD, Zimmermann M. Brainstem peptidergic neurons projecting to the medial and lateral thalamus and zona incerta in the rat. Brain Res 1993;603:47–56.

34. Levin MC, Sawchenko PE, Howe PRC, Bloom SR, Polak JM. Organization of galanin-immunoreactive inputs to the paraventricular nucleus with special reference to their relationship to catecholaminergic afferents. J Comp Neurol 1987;261:562–582.

35. Malin DH, Novy BJ, Lett-Brown AE, Plotner RE, May BT, Radulescu SJ, Crothers MK, Osgood LD, Lake JR. Galanin attenuates retention of one-trial reward learning. Life Sci 1992;50:939–944.

36. Mastropaolo J, Nadi N, Ostrowski NL, Crawley JN. Galanin antagonizes acetylcholine on a memory task in basal forebrain-lesioned rats. Proc Natl Acad Sci USA 1988;85:9841–9845.

37. Melander T, Hökfelt T, Rokaeus A. Distribution of galaninlike immunoreactivity in the rat central nervous system. J Comp Neurol 1986;248:475–517.

38. Melander T, Kohler C, Nilsson S, Hökfelt T, Brodin E, Theodorsson E, Bartfai T. Autoradiographic quantitation and anatomical mapping of 125I-galanin binding sites in the rat central nervous system. J Chem Neuroanat 1988;1:213–233.

39. Mufson EJ, Cochran E, Benzing W, Kordower JH. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Dementia 1993;4:237–250.

40. Nestler EJ. Molecular mechanisms of drug addiction. J Neurosci 1992;12:2439–2450.

41. Nishibori M, Oishi R, Itoh Y, Saeki K. Galanin inhibits noradrenaline-induced accumulation of cyclic AMP in the rat cerebral cortex. J Neurochem 1988;51:1953–1955.

42. Ögren SO, Hökfelt T, Kask K, Langel Ü, Bartfai T. Evidence for a role of the neuropeptide galanin in spatial learning. Neuroscience 1992;51:1–5.

43. Poggioli R, Rasori E, Bertolini A. Galanin inhibits sexual behavior in male rats. Eur J Pharmacol 1992;213:87–90.

44. Robinson JK, Crawley JN. Intraventricular galanin impairs delayed non-matching to sample performance in rats. Behav Neurosci 1993;107:458–467.

45. Sabatino FD, Collins P, McDonald JK. Neuropeptide Y stimulation of luteinizing hormone-releasing hormone secretion from median eminence in vitro by estrogen dependent and Ca+2 independent mechanisms. Endocrinology 1989;124:2089–2098.

46. Sawchenko PE, Pfeiffer SW. Ultrastructural localization of neuropeptide Y and galanin immunoreactivity in the paraventricular nucleus of the hypothalamus in the rat. Brain Res 1988;474:231–245.

47. Sawchenko PE, Swanson LW, Grzanna R, Howe PRC, Bloom SR, Polak JM. Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 1985;241:138–153.

48. Schultzberg M, Austin MC, Crawley JN, Paul SM. Repeated administration of desmethylimipramine blocks the reserpine-induced increase in tyrosine hydroxylase mRNA in locus coeruleus neurons of the rat. Mol Brain Res 1991;10:307–314.

49. Seutin V, Verbanck P, Massotte L, Dresse A. Galanin decreases the activity of the locus coeruleus neurons in vitro. Eur J Pharmacol 1989;164:373–376.

50. Sevcik J, Finta EP, Illes P. Galanin receptors inhibit the spontaneous firing of locus coeruleus neurones and interact with m-opiate receptors. Eur J Pharmacol 1993;230:223–230.

51. Skofitsch G, Jacobowitz DM. Quantitative distribution of galanin-like immunoreactivity in the rat central nervous system. Peptides 1985;7:609–613.

52. Skofitsch G, Sills MA, Jacobowitz DM. Autoradiographic distribution of 125I-galanin binding sites in the rat central nervous system. Peptides 1986;7:1029–1042.

53. Smith MA, Brady LS, Glowa J, Gold PW, Herkenham M. Effects of stress and adrenalectomy on tyrosine hydroxylase mRNA levels in the locus coeruleus by in situ hybridization. Brain Res 1991;544:26–32.

54. Stanley BG, Leibowitz SF. Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc Natl Acad Sci USA 1985;82:3940–3943.

55. Sutin EL, Jacobowitz DM. Immunocytochemical localization of peptides and other neurochemicals in the rat laterodorsal tegmental nucleus and adjacent area. J Comp Neurol 1988;270:243–270.

56. Tatemoto K. Neuropeptide Y and its receptor antagonists. In: Allen JM, Koenig JI, eds. Central and peripheral significance of neuropeptide Y and its related peptides. New York: New York Academy of Sciences, 1990;1–6.

57. Tsuda K, Tsuda S, Goldstein M, Masuyama Y. Effects of neuropeptide Y on norepinephrine release in hypothalamic slices of spontaneously hypertensive rats. Eur J Pharmacol 1990;182:175–179.

58. Vrontakis ME, Peden LM, Duckworth ML, Friesen HG. Isolation and characterization of a complementary DNA (galanin) clone from estrogen-induced pituitary tumor messenger RNA. J Biol Chem 1987;262:16755–16758.

59. Wahlestedt C, Grundemar L, Hakanson R, Heilig M, Shen GH, Zukowska-Grojec Z, Reis DJ. Neuropeptide Y receptor subtypes, Y1 and Y2. In: Central and peripheral significance of neuropeptide Y and its related peptides. Allen JM, Koenig JI, eds. New York: New York Academy of Sciences, 1990;7–26.

60. Wahlestedt C, Pich EM, Koob GF, Yee F, Heilig M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 1993;259:528–531.

61. Wiesenfeld-Hallin Z, Xu XJ, Hakanson R, Feng DM, Folkers K. Low-dose intrathecal morphine facilitates the spinal flexor reflex by releasing different neuropeptides in rats with intact and sectioned peripheral nerves. Brain Res 1990;551:157–162.

62. Wilcox BJ, Unnerstall JR. Identification of a subpopulation of neuropeptide Y-containing locus coeruleus neurons that project to the entorhinal cortex. Synapse 1990;6:284–291.

63. Xu XJ, Wiesenfeld-Hallin Z, Villar MJ, Fahrenkrug J, Hökfelt T. On the role of galanin, substance P and other neuropeptides in primary sensory neurons of the rat: studies on spinal reflex excitability and peripheral axotomy. Eur J Neurosci 1990;2:733–743.

Back to Chapter

published 2000